Your browser doesn't support javascript.
loading
PD-L1 - inhibitors in neuroendocrine neoplasia: Results from a real-life study.
Özdirik, Burcin; Jann, Henning; Bischoff, Philip; Fehrenbach, Uli; Tacke, Frank; Roderburg, Christoph; Wiedenmann, Bertram.
Afiliação
  • Özdirik B; Charité - University Medicine Berlin, Department of Hepatology & Gastroenterology, Campus Virchow Klinikum and Charité Campus Mitte.
  • Jann H; Charité - University Medicine Berlin, Department of Hepatology & Gastroenterology, Campus Virchow Klinikum and Charité Campus Mitte.
  • Bischoff P; Charité - University Medicine Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology.
  • Fehrenbach U; Charité - University Medicine Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Radiology, Berlin, Germany.
  • Tacke F; Charité - University Medicine Berlin, Department of Hepatology & Gastroenterology, Campus Virchow Klinikum and Charité Campus Mitte.
  • Roderburg C; Charité - University Medicine Berlin, Department of Hepatology & Gastroenterology, Campus Virchow Klinikum and Charité Campus Mitte.
  • Wiedenmann B; Charité - University Medicine Berlin, Department of Hepatology & Gastroenterology, Campus Virchow Klinikum and Charité Campus Mitte.
Medicine (Baltimore) ; 100(1): e23835, 2021 Jan 08.
Article em En | MEDLINE | ID: mdl-33429744
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Neuroendócrino / Inibidores de Checkpoint Imunológico Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Neuroendócrino / Inibidores de Checkpoint Imunológico Idioma: En Ano de publicação: 2021 Tipo de documento: Article